The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011

Charles E.R. Ray, Ziv J. Haskal, Jean Francois H. Geschwind, Brian S. Funaki

Research output: Contribution to journalComment/debate

Abstract

This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, "There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)."

Original languageEnglish (US)
Pages (from-to)1693-1696
Number of pages4
JournalJournal of Vascular and Interventional Radiology
Volume22
Issue number12
DOIs
StatePublished - Dec 2011

Keywords

  • HCC
  • hepatocellular carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011'. Together they form a unique fingerprint.

  • Cite this